Sun Pharma Advances Dermatology at AAD Annual Meeting
Sun Pharma made headlines at the 2026 AAD Annual Meeting with 14 abstracts, highlighting their advancements in dermatology and patient care.
clinical trials
Crs: Cytokine Release Syndrome () and Carpenter Technology Update
Aptevo Therapeutics has reported promising results in treating AML without CRS, while Carpenter Technology shows strong stock performance.
Gavi’s New Vaccine Budgets and Their Impact
Gavi has implemented new vaccine budgets aimed at improving resource distribution among its partner countries, enhancing vaccine accessibility.
South Korea Faces Historic Stock Market Plunge Amid Global Tensions
South Korea’s stock market has recorded its steepest fall in history, driven by the ongoing US-Iran war. The KOSPI index has plummeted significantly, impacting various sectors.